Your browser doesn't support javascript.
loading
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.
Assatova, Bimarzhan; Willim, Robert; Trevisani, Christopher; Haskett, Garrett; Kariya, Khyati Maulik; Chopra, Kusha; Park, Sung Rye; Tolstorukov, Michael Yevgeniy; McCabe, Sean M; Duffy, Jessica; Louissaint, Abner; Huuhtanen, Jani; Bhattacharya, Dipabarna; Mustjoki, Satu; Koh, Min Jung; Powers, Foster; Morgan, Elizabeth A; Yang, Lei; Pinckney, Brandy; Cotton, Matthew J; Crabbe, Andrew; Ziemba, Jessica Beth; Brain, Ian; Heavican-Foral, Tayla B; Iqbal, Javeed; Nemec, Ronald; Rider, Anna Baird; Ford, Josie Germain; Koh, Min Ji; Scanlan, Nora; Feith, David J; Loughran, Thomas P; Kim, Won Seog; Choi, Jaehyuk; Roels, Juliette; Boehme, Lena; Putteman, Tom; Taghon, Tom; Barnes, Jeffrey A; Johnson, P Connor; Jacobsen, Eric D; Greenberg, Steven A; Weinstock, David M; Jain, Salvia.
Afiliação
  • Assatova B; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Willim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Trevisani C; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Haskett G; Harvard Medical School, Boston, Massachusetts.
  • Kariya KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chopra K; College of Medicine, SUNY Upstate Medical University, Syracuse, New York.
  • Park SR; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Tolstorukov MY; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • McCabe SM; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Duffy J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Louissaint A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Huuhtanen J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Bhattacharya D; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Mustjoki S; Harvard Medical School, Boston, Massachusetts.
  • Koh MJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Powers F; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Morgan EA; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Yang L; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Pinckney B; School of Medicine, Georgetown University, Washington, District of Columbia.
  • Cotton MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Crabbe A; Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Ziemba JB; Harvard Medical School, Boston, Massachusetts.
  • Brain I; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Heavican-Foral TB; MD Anderson UTH Health Graduate School of Biomedical Sciences, Houston, Texas.
  • Iqbal J; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Nemec R; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Rider AB; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Ford JG; Department of Pathology, Akron General, Cleveland Clinic, Akron, Ohio.
  • Koh MJ; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Scanlan N; Histopath, Inc, Corpus Christi, Texas.
  • Feith DJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Loughran TP; Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.
  • Kim WS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Choi J; Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
  • Roels J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Boehme L; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Putteman T; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Taghon T; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Barnes JA; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
  • Johnson PC; Department of Medicine, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Jacobsen ED; Department of Medicine, University of Virginia Cancer Center, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Greenberg SA; Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea.
  • Weinstock DM; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Jain S; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.
Clin Cancer Res ; 30(11): 2514-2530, 2024 Jun 03.
Article em En | MEDLINE | ID: mdl-38252421
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Lectinas Tipo C Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Imunológicos / Lectinas Tipo C Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article